UBS Downgrades Par Pharmaceutical (PRX) To 'Neutral', Says Lower Possibility Of Another Bid
Posted on August 08, 2012 at 12:57 PM EDT
Par Pharmaceutical Companies Inc. (NYSE:PRX) shares were downgraded to "Neutral" from "Buy" by UBS Securities, which said likelihood of another bidder for the maker of generic drugs is less likely than expected earlier. [More...]
Stock Market XML and JSON Data API provided by FinancialContent Services, Inc.
Nasdaq quotes delayed at least 15 minutes, all others at least 20 minutes.
Markets are closed on certain holidays. Stock Market Holiday List
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.
Press Release Service provided by PRConnect.
Stock quotes supplied by Telekurs USA
Postage Rates Bots go here
Nasdaq quotes delayed at least 15 minutes, all others at least 20 minutes.
Markets are closed on certain holidays. Stock Market Holiday List
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.
Press Release Service provided by PRConnect.
Stock quotes supplied by Telekurs USA
Postage Rates Bots go here